Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer
- 1 July 2000
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36, 17-25
- https://doi.org/10.1016/s0959-8049(00)00081-2
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinumEuropean Journal Of Cancer, 1998
- Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.Journal of Clinical Oncology, 1997
- Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.Journal of Clinical Oncology, 1997
- An eastern cooperative oncology group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaCancer, 1994
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumorsCancer, 1991
- Chemotherapy of urothelial tract tumorsCancer, 1987
- Phase III Comparison of Cisplatin Alone Versus Cisplatin, Doxorubicin and Cyclophosphamide in the Treatment of Bladder (Urothelial) Cancer: A Southeastern Cancer Study Group TrialJournal of Urology, 1987
- Cis-Diamminedichloride Platinum II in the Treatment of Abvanced Bladder CancerJournal of Urology, 1980
- Cis-Diamminebichloroplatinum as a Therapeutic Agent in Metastatic Transitional Cell CarcinomaJournal of Urology, 1980